Catherine C. Going

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also affiliated with Stanford University

ChemistryBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “SU086, an inhibitor of HSP90, impairs glycolysis and represents a treatment strategy for advanced prostate cancer”.

SU086, an inhibitor of HSP90, impairs glycolysis and represents a treatment strategy for advanced prostate cancer

Cell Reports Medicine(2022)10.1016/j.xcrm.2021.100502

N/A

0DataRank · unranked

35 citations

VINEET KUMAR, Dhanir Tailor, Fernando Jose Garcia-Marques, En‐Chi Hsu, Shiqin Liu +23 more